Hubungan antara Resistensi Insulin dan Kadar Hepsidin (Regulator Zat Besi) Terhadap Fenotipe Sindrom Ovarium Polikistik (SOPK)

Brilian Segala Putra; Nusratuddin Abdullah; Fatmawaty Madya; St. Nur Asni; Andi Mardiah Tahir; Lenny Lisal

doi:10.24198/obgynia/v6n1.472

Hubungan antara Resistensi Insulin dan Kadar Hepsidin (Regulator Zat Besi) Terhadap Fenotipe Sindrom Ovarium Polikistik (SOPK)

Brilian Segala Putra,^(1*) Nusratuddin Abdullah,⁽²⁾ Fatmawaty Madya,⁽³⁾ St. Nur Asni,⁽⁴⁾ Andi Mardiah Tahir,⁽⁵⁾ Lenny Lisal,⁽⁶⁾

(1) Hasanuddin University
(2) Departemen Obstetri dan Ginekologi, Fakultas Kedokteran Universitas Hasanuddin, Indonesia
(3) Departemen Obstetri dan Ginekologi, Fakultas Kedokteran Universitas Hasanuddin, Indonesia
(4) Departemen Obstetri dan Ginekologi, Fakultas Kedokteran Universitas Hasanuddin, Indonesia
(5) Departemen Obstetri dan Ginekologi, Fakultas Kedokteran Universitas Hasanuddin, Indonesia
(6) Departemen Obstetri dan Ginekologi, Fakultas Kedokteran Universitas Hasanuddin, Indonesia
(*) Corresponding Author

Abstract

Tujuan: Penelitian ini bertujuan untuk mengetahui hubungan antara Resistensi Insulin dan kadar hepsidin serum terhadap fenotipe Sindrom Ovarium Polikistik (SOPK). Resistensi insulin dan hiperinsulinisme yang terjadi pada SOPK dapat meningkatkan eritropoiesis, yang dapat menyebabkan penurunan regulasi ekspresi hepsidin
Metode: Penelitian ini menggunakan metode cross sectional dan dilakukan di beberapa rumah sakit pendidikan di Makassar, Indonesia. Kami memasukkan pasien yang didiagnosis dengan sindrom ovarium polikistik (SOPK) berusia 18-40 tahun. Resistensi Insulin diperiksa mengunakan metode HOMA-IR dan kadar hepsidin diperiksa menggunakan metode enzyme-linked immunosorbent assay (ELISA) pada semua subjek yang memenuhi syarat. Hasil yang diperoleh selanjutnya dianalisis secara statistik.
Hasil: Sebanyak 52 pasien SOPK dilibatkan dalam penelitian ini, 40 pasien dengan resistensi insulin dan 12 pasien tanpa resistensi insulin. Setelah memeriksa kadar hepsidin serum, kami tidak menemukan perbedaan resistensi insulin diantara keempat fenotipe SOPK (p>0,05), namun terdapat perbedaan kadar hepsidin SOPK fenotipe A dengan fenotipe C (p<0,05). Kami juga menemukan korelasi negatif sedang antara kadar hepsidin serum dengan homeostatic model assessment for insulin resistance (HOMA-IR) (r=-0,419; p<0,05).
Kesimpulan : Terdapat hubungan yaitu semakin tinggi resistensi insulin, semakin rendah kadar hepsidin serum. Dan tidak terdapat perbedaan resistensi insulin pada SOPK diantara keempat fenotipe namun terdapat perbedaan kadar hepsidin serum yang lebih tinggi pada SOPK fenotipe A dibanding SOPK fenotipe C

Correlation between Insulin Resistance and Hepcidin Levels (Iron Regulator) and Polycystic Ovarian Syndrome Phenotype

Abstract
Objective: The goal of this study was to know the relationship between Insulin Resistance and serum hepcidin levels on Polycystic Ovarian Syndrome (PCOS) phenotype. Insulin Resistance and hyperinsulinism in PCOS promote erythropoiesis which can result in downregulation of hepcidin expression
Methods: This study uses a cross sectional and was conducted at several educational hospitals in Makassar, Indonesia. We included patients diagnosed with polycystic ovarian syndrome (PCOS) aged 18-40 years. Insulin resistance was checked using the HOMA-IR method and hepcidin levels were checked using the enzyme-linked immunosorbent assay (ELISA) method on all subjects meeting the requirement. The results obtained will then be analyzed statistically.
Results: 52 PCOS patients are included in this study, 40 patients with insulin resistance and 12 ones without insulin resistance. After examining the serum hepcidin level, we did not find a difference in insulin resistance among the four PCOS phenotypes (p>0.05), however there is PCOS level difference of phenotype A and phenotype C (p<0.05). We observed as well medium negative correlation between serum hepcidin level and the homeostatic model assessment for insulin resistance (HOMA-IR) (r=-0.419; p<0.05).
Conclusions: Correlation is found where the higher the insulin resistance, the lower the hepcidin serum level. Also no difference is observed in insulin resistance of PCOS among the four phenotypes, however serum hepcidin level difference is indicated higher on PCOS phenotype A compared to that of PCOS phenotype C.

Key words: polycystic ovarian syndrome, hepcidin, insulin resistance

Keywords

sindrom ovarium polikistik, hepsidin, resistensi insulin.

Full Text:

PDF

References

Kabel MA. Polycystic ovarian syndrome: insights into pathogenesis, diagnosis, prognosis, pharmacological and non- pharmacological treatment. 1Department Pharmacol Fac Med Tanta Univ Tanta Egypt. 2016;

McCartney CR, Marshall JC. Polycystic Ovary Syndrome. Solomon CG, editor. N Engl J Med. 2016 Jul 7;375(1):54–64.

O’Reilly MW, Taylor AE, Crabtree NJ, Hughes BA, Capper F, Crowley RK, et al. Hyperandrogenemia Predicts Metabolic Phenotype in Polycystic Ovary Syndrome: The Utility of Serum Androstenedione. J Clin Endocrinol Metab. 2014 Mar 1;99(3):1027–36.

Rosa Maciel GA. Polycystic Ovary Syndrome: Correlation between Phenotypes and Metabolic Syndrome. J Steroids Horm Sci [Internet]. 2013 [cited 2020 May 10];05(02). Available from: https://www.omicsonline.org/open-access/polycystic-ovary-syndrome-correlation-between-phenotypes-and-metabolic-syndrome-2157-7536.1000132.php?aid=26395

Shariat M, Haghollahi F, Bagheri M. The Association of Serum Hepcidin Levels and Insulin Resistance in PCOS Patients: A Case-Control Study. 2018;210–6.

Alebić MŠ, Bulum T, Stojanović N, Duvnjak L. Definition of insulin resistance using the homeostasis model assessment (HOMA-IR) in IVF patients diagnosed with polycystic ovary syndrome (PCOS) according to the Rotterdam criteria. Endocrine. 2014 Feb 13;47(2):625–30.

Luque-Ramírez M, Álvarez-Blasco F, Alpañés M, Escobar-Morreale HF. Role of Decreased Circulating Hepcidin Concentrations in the Iron Excess of Women with the Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2011 Mar 1;96(3):846–52.

Yeon Lee J, Baw CK, Gupta S, Aziz N, Agarwal A. Role of Oxidative Stress in Polycystic Ovary Syndrome. Curr Womens Health Rev. 2010 May 1;6(2):96–107.

Lucidi R. What is the modified Ferriman-Gallwey (mFG) scoring system and how is it used in the evaluation of suspected polycystic ovarian syndrome (PCOS)? Medscape [Internet]. 2019; Available from: https://www.medscape.com/answers/256806-26811/what-is-the-modified-ferriman-gallwey-mfg-scoring-system-and-how-is-it-used-in-the-evaluation-of-suspected-polycystic-ovarian-syndrome-pcos

Kali A, Charles MVP, Seetharam RSK. Hepcidin - A novel biomarker with changing trends. Pharmacogn Rev. 2015 Jun;9(17):35–40.

D’Angelo G. Role of hepcidin in the pathophysiology and diagnosis of anemia. Blood Res. 2013;48(1):10.

Marshall JC, Dunaif A. Should all women with PCOS be treated for insulin resistance? Fertil Steril. 2012 Jan;97(1):18–22.

Anwar A. Hubungan kadar leptin serum dengan kejadian resistensi insulin pada penderita sindrom ovarium polikistik. 2020;

Bode D, Seehusen DA, Baird D. Hirsutism in women. Am Fam Physician. 2012 Feb 15;85(4):373–80.

Belenkaia LV, Lazareva LM, Walker W, Lizneva DV, Suturina LV. Criteria, phenotypes and prevalence of polycystic ovary syndrome. Minerva Ginecol [Internet]. 2019 May [cited 2022 Jul 14];71(3). Available from: https://www.minervamedica.it/index2.php?show=R09Y2019N03A0211

Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril. 2016 Jul;106(1):6–15.

Khan MJ, Ullah A, Basit S. Genetic Basis of Polycystic Ovary Syndrome (PCOS): Current Perspectives. Appl Clin Genet. 2019 Dec;Volume 12:249–60.

Sachdeva G, Gainder S, Suri V, Sachdeva N, Chopra S. Comparison of the Different PCOS Phenotypes Based on Clinical Metabolic, and Hormonal Profile, and their Response to Clomiphene. Indian J Endocrinol Metab. 2019;

Escobar-Morreale HF. Iron metabolism and the polycystic ovary syndrome. Trends Endocrinol Metab. 2012 Oct;23(10):509–15.

Kim JW, Kang KM, Yoon TK, Shim SH, Lee WS. Study of circulating hepcidin in association with iron excess, metabolic syndrome, and BMP-6 expression in granulosa cells in women with polycystic ovary syndrome. Fertil Steril. 2014 Aug;102(2):548-554.e2.

Hossein Rashidi B, Shams S, Shariat M, Bagheri M, Mohebi M, Haghollahi F. The Association of Serum Hepcidin Levels and Insulin Resistance in PCOS Patients: A Case-Control Study. J Fam Reprod Health. 2018 Dec;12(4):210–6.

Sam AH, Busbridge M, Amin A, Webber L, White D, Franks S, et al. Hepcidin levels in diabetes mellitus and polycystic ovary syndrome. Diabet Med. 2013 Dec;30(12):1495–9.

Wang H, Li H, Jiang X, Shi W, Shen Z, Li M. Hepcidin Is Directly Regulated by Insulin and Plays an Important Role in Iron Overload in Streptozotocin-Induced Diabetic Rats. Diabetes. 2014 May 1;63(5):1506–18.

DOI: http://dx.doi.org/10.24198/obgynia/v6n1.472